Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now later-stage tilt small index

Gestational Hypertension: later-stage trial registry

13 of 19 indexed Gestational Hypertension trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #902 of 28,707 conditions by registered trial count.

19 US clinical trials · 13 currently recruiting · #902 of 28,707 conditions by registered trial count

Gestational Hypertension: 19 US clinical trials tracked, 13 recruiting.

Gestational Hypertension is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University, running 2 of these trials.

Enrollment posture brief

Registry condition gestational-hypertension

OPEN 13 | RECR 68% | LATE 4 | EARLY 1 | RANK #902 | SPON 2

Nearest open-share peer: Hormone Receptor-Positive Breast Carcinoma (68% recruiting · 19 trials)

Gestational Hypertension (th…68%Amyotrophic Lateral Sclerosi52.6%Anesthesia, Local42.1%Alcohol Consumption36.8%Attention Deficit Hyperactiv26.3%
Open-enrollment share among volume-matched conditions near Gestational Hypertension

Gestational Hypertension lists 13 open slots (68% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gestational Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gestational Hypertension is recruiting above its size-band peers.

    13 of 19 indexed trials (68.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Gestational Hypertension trials is spread across many organizations.

    Ohio State University accounts for 2 of 19 trials (10.5%). 17 distinct sponsors appear on at least one study for this condition label.

  3. Typical Gestational Hypertension enrolment sits around 132 participants.

    Median target enrolment is 132 among the 19 trials that report a genuine target (sentinel values excluded). 4 of those (21.1%) plan for fewer than 100 participants.

  4. Gestational Hypertension research is mostly interventional.

    16 interventional and 3 observational studies make up this index (84.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 44

Open and recent trials

19 total, page 1 of 1

RECRUITING Phase 4 10,742 participants

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Ohio State University

NCT06468202

RECRUITING NA 1,440 participants

Delivering HOPE (Helping Women Optimize Prenatal Equity)

University of Arkansas

NCT06814509

RECRUITING NA 296 participants

Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education

Ochsner Health System

NCT06920563

RECRUITING NA 250 participants

Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women

Christiana Care Health Services

NCT06180811

RECRUITING Phase 2 204 participants

Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories

Massachusetts General Hospital

NCT07041281

RECRUITING Phase 4 200 participants

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

University of Michigan

NCT06785116

RECRUITING NA 132 participants

The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.

University of Alabama at Birmingham

NCT05676476

RECRUITING NA 120 participants

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Northwestern University

NCT06523569

RECRUITING NA 100 participants

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

University of Massachusetts, Worcester

NCT06835959

RECRUITING NA 100 participants

Preventing Obstetric Complications With Dietary Intervention

Medical College of Wisconsin

NCT06320054

RECRUITING Phase 4 76 participants

AtorvaStatin Postpartum and Reduction of Cardiovascular risK

Ohio State University

NCT06632379

RECRUITING 75 participants

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

Weill Medical College of Cornell University

NCT06647511

RECRUITING Phase 4 60 participants

Treatment With Aspirin After Preeclampsia: TAP Trial

Malamo Countouris

NCT06281665

ACTIVE NOT RECRUITING 10,000 participants

MIRACLE of LIFE Study

Mirvie

NCT06074601

COMPLETED NA 224 participants

Nudge to Drive Transitions of Care

University of Pennsylvania

NCT04660032

COMPLETED NA 148 participants

Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia

University of Pittsburgh

NCT03749746

COMPLETED NA 128 participants

Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy

University of Pennsylvania

NCT04119232

COMPLETED NA 120 participants

App-based Remote Blood Pressure Monitoring

Women and Infants Hospital of Rhode Island

NCT05595629

COMPLETED 26 participants

User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study

University of Colorado, Denver

NCT02384226

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 4

Named interventions

Most-linked intervention names on Gestational Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
Heart Health 4 New Moms Behavioral
1 trials
Home Blood Pressure Monitoring Behavioral
1 trials
Social incentives-based program Behavioral
1 trials
text-message based remote blood pressure monitoring Behavioral
1 trials
App-based remote blood pressure monitoring Behavioral
1 trials
Nudge Behavioral
1 trials
Mirvie Predictive Test for Adverse Pregnancy Outcomes Diagnostic test
1 trials

US sites by state

Facility locations filed on Gestational Hypertension trials. A trial with sites in several states counts in each.

Pennsylvania 7 trials
Ohio 3 trials
Massachusetts 3 trials
Louisiana 3 trials
Wisconsin 2 trials
Texas 2 trials
Rhode Island 2 trials
New York 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gestational Hypertension page

19 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 13 Gestational Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Ohio State University sponsors the most Gestational Hypertension trials on record, review their full trial history before evaluating a specific study. See Ohio State University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gestational Hypertension condition card totals 19 registered trials; most-linked intervention Placebo; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.